Provide a key summary of new updates of the Surviving Sepsis Guidelines for both Adults and Pediatrics

Comment by InpharmD Researcher

The 2026 Surviving Sepsis Campaign (SSC) guidelines for adults and pediatrics provide updated, more individualized recommendations for the recognition and management of sepsis and septic shock. Key updates and comparisons to prior guidelines are summarized in Table 1 (adults) and Table 2 (pediatrics).

surviving sepsis campaign

Literature Review

A search of the published medical literature revealed 2 studies investigating the researchable question:

Provide a key summary of new updates of the Surviving Sepsis Guidelines for both Adults and Pediatrics

Level of evidence

C - Multiple studies with limitations or conflicting results  Read more→



Please see Tables 1-2 for your response.


Recommendation

2026 Surviving Sepsis Campaign

2020 Surviving Sepsis Campaign

Change from 2020 to 2026

Patient Assessment

Systematic screening

For children who are acutely unwell, there was insufficient evidence to recommend implementing systematic sepsis screening, in addition to established clinical protocols, for the timely recognition of sepsis and septic shock.

In children who present as acutely unwell, we suggest implementing systematic screening for timely recognition of septic shock and other sepsis-associated organ dysfunction (weak recommendation, very low quality of evidence).

Updated

Blood Lactate

For children with probable sepsis or suspected septic shock, we recommend measuring blood lactate as part of initial evaluation and management (strong recommendation, very low certainty evidence).

Unable to issue a recommendation about using blood lactate values to stratify children with suspected septic shock or other sepsis-associated organ dysfunction into low- versus high-risk of having septic shock or sepsis.

Updated

Hospital protocol / performance improvement

For children with sepsis or septic shock, we recommend that hospitals implement a performance improvement program, including standard operating procedures for treatment (strong recommendation, low certainty of evidence).

We recommend implementing a protocol/guideline for management of children with septic shock or other sepsis-associated organ dysfunction (BPS).

Updated

Routine molecular pathogen testing

For children with probable sepsis or suspected/confirmed septic shock, there was insufficient evidence to issue a recommendation for or against routine molecular testing for pathogen detection or identification.

Not listed in the 2020 summary recommendations. 

New

Hemodynamic Management

Ongoing clinical assessment of hemodynamic status

Resuscitation for children with sepsis or septic shock should be guided by ongoing clinical assessment of markers of hemodynamic status, including heart rate, blood pressure, capillary refill time, extremity temperature, pulse quality, level of consciousness, and urine output (GPS).

No parallel standalone recommendation in 2020; these markers appeared in remarks tied to fluid reassessment.

New

Advanced hemodynamic monitoring

For children with sepsis and septic shock, there was insufficient evidence to issue a recommendation on use of advanced hemodynamic monitoring along with bedside clinical signs to guide resuscitation.

We suggest using advanced hemodynamic variables, when available, in addition to bedside clinical variables to guide resuscitation of children with septic shock or other sepsis-associated organ dysfunction (weak recommendation, low quality of evidence).

Updated

ScvO2 target

For children with septic shock, we suggest targeting ScvO2 ≥ 70% when central venous access is available, over not targeting ScvO2 (conditional recommendation, very low certainty evidence).

In 2020, ScvO2 was included under advanced monitoring, but not as a standalone recommendation

Updated

Antimicrobial Management

Antibiotics for suspected septic shock

For children with suspected septic shock, we recommend starting antimicrobial therapy as soon as possible, ideally within 1 hour of recognition of sepsis (strong recommendation, very low certainty of evidence).

In children with septic shock, we recommend starting antimicrobial therapy as soon as possible, within 1 hour of recognition (strong recommendation, very low quality of evidence).

Updated

Antibiotics for sepsis without shock

For children with probable sepsis without shock, we suggest a time-limited course of rapid investigation and, if concern for sepsis is substantiated, starting antimicrobial therapy as soon as possible after appropriate evaluation, ideally within 3 hours of recognition (conditional recommendation, very low certainty of evidence).

In children with sepsis-associated organ dysfunction but without shock, we suggest starting antimicrobial therapy as soon as possible after appropriate evaluation, within 3 hours of recognition (weak recommendation, very low quality of evidence).

Updated

Fluid Therapy

Initial bolus fluids in systems with intensive care availability

For children with septic shock being treated in healthcare systems with intensive care availability, we suggest administering up to 40–60 mL/kg in bolus fluid (10–20 mL/kg per bolus) over the first hour of initial resuscitation, over no fluid bolus (conditional recommendation, low certainty evidence).

In healthcare systems with availability of intensive care, we suggest administering up to 40–60 mL/kg in bolus fluid (10–20 mL/kg per bolus) over the first hour, titrated to clinical markers of cardiac output and discontinued if signs of fluid overload develop (weak recommendation, low quality of evidence).

Updated Wording

Vasoactive Medications

Peripheral vasoactive access

For children with septic shock requiring vasoactive medications, we suggest initiating vasoactive medications through peripheral venous access over delaying therapy until central venous access is obtained (conditional recommendation, very low certainty of evidence).

Unable to issue a recommendation about initiating vasoactive agents through peripheral access in children with septic shock; remarks stated peripheral epinephrine or norepinephrine may be used if central access is not readily accessible.

Updated

Ventilation / Oxygenation

Oxygen targets

For intubated children with sepsis or

septic shock following resuscitation, we suggest titrating supplemental oxygen to target a conservative range (Spo2 88–92%) over a more liberal target (Spo2 > 94%; conditional recommendation,

moderate certainty of evidence).

No specific oxygen target recommendation

New

Long-term Outcomes / Follow-up

Early rehabilitation

For children with sepsis or septic shock, we suggest implementing an individualized, early rehabilitation bundle during the acute illness rather than not using a rehabilitation bundle (conditional recommendation, very low certainty evidence).

Not addressed

New

Targeted post-hospital follow-up

For children with sepsis or septic shock, there was insufficient evidence to recommend for or against targeted post-hospital follow-up.

Not addressed

New

Post-sepsis morbidity assessment after discharge

For children who survive sepsis or septic shock, it is reasonable to: 1) assess risk factors for post-sepsis morbidity, 2) educate the patient, family, and clinicians on the symptoms of post-sepsis morbidity, and 3) evaluate for new, long-term sequelae after hospital discharge (GPS).

Not addressed



New 

 

References:
[1] [1] Weiss SL, Peters MJ, Oczkowski SJW, et al. Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026. Pediatr Crit Care Med. Published online March 23, 2026. doi:10.1097/PCC.0000000000003927
[2] [2] Prescott HC, Antonelli M, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Crit Care Med. Published online March 23, 2026. doi:10.1097/CCM.0000000000007075
[3] [3] Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181-1247. doi:10.1007/s00134-021-06506-y

Recommendation

2026 Surviving Sepsis Campaign

2021 Surviving Sepsis Campaign

Change from 2021 to 2026

Patient Assessment

 

Scoring tools

For acutely ill hospitalized patients, recommend use of NEWS/NEWS2 or MEWS or SIRS over the qSOFA (strong, moderate evidence) 

Recommend against using qSOFA compared with SIRS, NEWS, or MEWS as a single-screening tool for sepsis or septic shock (strong, moderate evidence) 

Unchanged (except addition of NEWS2)

Blood lactate

For adults with possible, probable, or definite sepsis or septic shock, suggest measuring blood lactate (conditional recommendation, low certainty evidence)

For adults suspected of having sepsis, suggest measuring blood lactate (weak, low-quality evidence)

Unchanged (clarified wording)

Hemodynamic Management

 

Blood pressure monitoring

Suggest using either invasive or non-invasive blood pressure monitoring modalities (conditional, very low evidence)

Preference for invasive over non-invasive blood pressure monitoring

Updated

Fluid Resuscitation

Balanced crystalloids vs saline

Suggest balanced crystalloids over 0.9% saline; note saline may be appropriate in Traumatic Brain Injury (TBI)

Suggested balanced crystalloids over saline

Strengthened evidence

Crystalloids vs albumin

Suggest crystalloids alone over crystalloids + albumin; avoid albumin in TBI (conditional, moderate evidence)

Suggested albumin in patients requiring large volumes of crystalloids

Updated

Fluid strategy after initial resuscitation

Suggest either liberal or restrictive fluid strategy after initial resuscitation (conditional, low evidence)

No recommendation (insufficient evidence)

New

Vasopressor / Adjunctive Therapies

Terlipressin

Suggest against terlipressin (conditional, low Level of Evidence [LOE])

Not specifically addressed

New

Methylene blue

No recommendation (insufficient evidence)

Not addressed

New

Midodrine

No recommendation (insufficient evidence)

Not addressed

New

Beta-blockers

Suggest against routine use of short-acting beta-blockers (e.g., esmolol, landiolol) outside of select circumstances

Previously discussed in select contexts without a formal recommendation



New/ Updated

Antimicrobial Management

 

Source control timing

Suggest early source control as soon as medically and logistically practical (often within ~6 hours) (conditional, very low evidence)

Recommend early/prompt source control (no specific timeframe)

Updated (clarified timing)

Empiric antifungal therapy

Recommend against routine empiric antifungal therapy

Suggest empiric antifungal therapy only in high-risk patients and avoid in low-risk patients

Strengthened against routine use

Beta-lactam infusion strategy

Recommend prolonged/extended infusion beta-lactams after loading dose (strong, moderate evidence)

Suggest prolonged infusion beta-lactams (weak recommendation)

Upgraded

De-escalation of antimicrobials

Recommend de-escalation once pathogen identified or infection ruled out (strong, very low evidence)

Suggest daily reassessment for de-escalation (weak recommendation)

Upgraded

Initial Resuscitation

Lactate-guided resuscitation

Suggest using serial lactate measurements to guide resuscitation (conditional, low evidence)

Suggest guiding resuscitation to decrease serum lactate in patients with elevated lactate (weak, low-quality evidence)

Updated

 

References:
[1] [1] Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181-1247. doi:10.1007/s00134-021-06506-y
[2] [2] Prescott HC, Antonelli M, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Crit Care Med. Published online March 23, 2026. doi:10.1097/CCM.0000000000007075